← back to search

Zhou Zhang

First People's Hospital of Chongqing · CN
Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Lung Cancer Research Studies, and Sperm and Testicular Function.
h-index
43
citations
6,559
works
289
NIH funding
primary concept
Medicine
email

Recent publications

5-Hydroxymethylated Biomarkers in Cell-Free DNA Predict Occult Colorectal Cancer up to 36 Months Before Diagnosis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
JCO Precision Oncology 2024cited by 4position: middledoi
Development and validation of a deep learning-based approach to predict the Mayo endoscopic score of ulcerative colitis
Therapeutic Advances in Gastroenterology 2023cited by 14position: middledoi
Association between anemia and the risk and outcomes of diabetic foot in patients with type 2 diabetes mellitus
Experimental and Therapeutic Medicine 2023cited by 9position: middledoi
bITH, a blood-based metric of intratumor heterogeneity, is associated with clinical response to immune checkpoint blockade in non-small cell lung cancer.
2023cited by 7position: contributordoi
Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma.
2022cited by 271position: contributordoi
Development and Validation of a Deep Neural Network for Accurate Identification of Endoscopic Images From Patients With Ulcerative Colitis and Crohn's Disease
Frontiers in Medicine 2022cited by 33position: middledoi
Distinct mutational features across preinvasive and invasive subtypes identified through comprehensive profiling of surgically resected lung adenocarcinoma.
2022cited by 20position: contributordoi
Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes.
2022cited by 14position: contributordoi
Expression of SAMHD1 and its mutation on prognosis of colon cancer
Oncology Letters 2022cited by 3position: firstdoi
Accuracy of next-generation sequencing for molecular profiling of small specimen of lung cancer: a prospective pilot study of side-by-side comparison.
2022cited by 2position: contributordoi
Comprehensive genomic profiling and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the stomach and parotid gland.
2022cited by 1position: contributordoi
Additional file 3 of Genome-wide profiling of 5-hydroxymethylcytosines in circulating cell-free DNA reveals population-specific pathways in the development of multiple myeloma
Open MIND 2022cited by 0position: middledoi
Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma
Cancer Cell 2021cited by 408position: middledoi
Distinctive genomic characteristics in <i>POLE/POLD1</i>-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor.
2021cited by 28position: contributordoi
HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma.
2021cited by 12position: contributordoi
High SHP2 expression determines the efficacy of PD-1/PD-L1 inhibitors in advanced KRAS mutant non-small cell lung cancer.
2021cited by 9position: contributordoi
Detection of Microsatellite Instability from Circulating Tumor DNA by Targeted Deep Sequencing.
2020cited by 40position: contributordoi
Salvianolic acid A increases the accumulation of doxorubicin in brain tumors through Caveolae endocytosis
Neuropharmacology 2020cited by 22position: lastdoi
Genetic mutation profile of Chinese HER2-positive breast cancers and genetic predictors of responses to Neoadjuvant anti-HER2 therapy.
2020cited by 10position: contributordoi
Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC.
2019cited by 88position: contributordoi
Characterization of frequently mutated cancer genes in Chinese breast tumors: a comparison of Chinese and TCGA cohorts.
2019cited by 53position: contributordoi
Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I trial.
2019cited by 37position: contributordoi
Molecular features of pleomorphic xanthoastrocytoma.
2019cited by 18position: contributordoi
Basonuclin 1 deficiency is a cause of primary ovarian insufficiency
Human Molecular Genetics 2018cited by 73position: middledoi
The influence of environmental factors on communities of arbuscular mycorrhizal fungi associated with Chenopodium ambrosioides revealed by MiSeq sequencing investigation
Scientific Reports 2017cited by 119position: middledoi
Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway
Nature Genetics 2014cited by 472position: middledoi
The draft genome of the large yellow croaker reveals well-developed innate immunity
Nature Communications 2014cited by 204position: middledoi
A Novel Function of MicroRNA 130a-3p in Hepatic Insulin Sensitivity and Liver Steatosis
Diabetes 2014cited by 82position: middledoi
Association analysis identifies new risk loci for non-obstructive azoospermia in Chinese men
Nature Communications 2014cited by 74position: middledoi
A Genome-Wide Association Study Identifies a Locus on TERT for Mean Telomere Length in Han Chinese
PLoS ONE 2014cited by 58position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Daizhan Zhou · Yangpu Hospital of Tongji University4 papers (2012–2014)Yi‐Long Wu · China Agricultural University3 papers (2019–2021)Lin He · South China Normal University3 papers (2013–2014)Qin Shen · Fudan University2 papers (2012–2014)Lan Cao · Fudan University2 papers (2012–2014)Junyi Ye · Fudan University2 papers (2014–2014)Yun Liu · Kunming Children's Hospital2 papers (2012–2014) · 2 papers (2020–2023)Xiaoling Weng · Fudan University2 papers (2014–2014) · 2 papers (2012–2014)Di Zhang · Los Alamos National Laboratory2 papers (2013–2014)Kai Li · Howard Hughes Medical Institute1 papers (2014–2014)Ran Chen · Anhui Medical University1 papers (2022–2022)Jin Zhang · Fudan University1 papers (2014–2014)Chen Chen · Nantong University1 papers (2017–2017)Ting Wang · Shenzhen University1 papers (2014–2014)Ting Wang · Nanjing Agricultural University1 papers (2014–2014)Hong Zhang · Fudan University1 papers (2014–2014)Ping Li · Nanchang University1 papers (2022–2022)Xu Zhang · Health Canada1 papers (2022–2022)